1. Home
  2. EYPT vs IQI Comparison

EYPT vs IQI Comparison

Compare EYPT & IQI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EYPT
  • IQI
  • Stock Information
  • Founded
  • EYPT 1987
  • IQI 1992
  • Country
  • EYPT United States
  • IQI United States
  • Employees
  • EYPT N/A
  • IQI N/A
  • Industry
  • EYPT Biotechnology: Laboratory Analytical Instruments
  • IQI Finance Companies
  • Sector
  • EYPT Industrials
  • IQI Finance
  • Exchange
  • EYPT Nasdaq
  • IQI Nasdaq
  • Market Cap
  • EYPT 594.5M
  • IQI 527.3M
  • IPO Year
  • EYPT 2005
  • IQI N/A
  • Fundamental
  • Price
  • EYPT $8.12
  • IQI $9.85
  • Analyst Decision
  • EYPT Strong Buy
  • IQI
  • Analyst Count
  • EYPT 8
  • IQI 0
  • Target Price
  • EYPT $27.29
  • IQI N/A
  • AVG Volume (30 Days)
  • EYPT 918.1K
  • IQI 162.1K
  • Earning Date
  • EYPT 11-07-2024
  • IQI 01-01-0001
  • Dividend Yield
  • EYPT N/A
  • IQI 4.61%
  • EPS Growth
  • EYPT N/A
  • IQI N/A
  • EPS
  • EYPT N/A
  • IQI N/A
  • Revenue
  • EYPT $45,713,000.00
  • IQI N/A
  • Revenue This Year
  • EYPT N/A
  • IQI N/A
  • Revenue Next Year
  • EYPT N/A
  • IQI N/A
  • P/E Ratio
  • EYPT N/A
  • IQI N/A
  • Revenue Growth
  • EYPT 7.50
  • IQI N/A
  • 52 Week Low
  • EYPT $7.21
  • IQI $8.05
  • 52 Week High
  • EYPT $30.99
  • IQI $10.00
  • Technical
  • Relative Strength Index (RSI)
  • EYPT 41.68
  • IQI 33.31
  • Support Level
  • EYPT $7.21
  • IQI $9.82
  • Resistance Level
  • EYPT $8.21
  • IQI $10.29
  • Average True Range (ATR)
  • EYPT 0.49
  • IQI 0.09
  • MACD
  • EYPT -0.02
  • IQI -0.03
  • Stochastic Oscillator
  • EYPT 42.82
  • IQI 11.22

About EYPT EyePoint Pharmaceuticals Inc.

EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.

About IQI Invesco Quality Municipal Income Trust

Invesco Quality Municipal Income Trust is a diversified, closed-end management investment company. Its investment objective is to provide current income which is exempt from federal income tax.

Share on Social Networks: